Keyphrases
Breast Cancer
100%
Estrogen Receptor
100%
Therapeutic Potential
100%
Bone Morphogenetic Protein 4 (BMP4)
100%
Pathway Signaling
100%
Antiestrogen
42%
ALK3
28%
Transcriptomic Signature
28%
Cyclin-dependent Kinase 4/6 Inhibitors
28%
BMP4 Signaling
28%
Phosphorylation
14%
RNA Sequencing (RNA-seq)
14%
Knockdown
14%
Growth Inhibition
14%
Breast Cancer Cell Lines
14%
Cell Growth
14%
Cell Cycle Arrest
14%
Recombinant
14%
Mammalian Target of Rapamycin (mTOR)
14%
Receptor Antagonist
14%
Primary Tumor
14%
Smad1
14%
Tumor Grade
14%
Immunoblot Analysis
14%
Disease Outcome
14%
Drug Development
14%
Estrogen Therapy
14%
RNA Interference
14%
Human Tumors
14%
Adjuvant Therapy
14%
Biologic Response
14%
Breast Tumor
14%
Systemic Therapy
14%
Cell Fate
14%
Tumor Microenvironment
14%
C(X)
14%
Estrogen Receptor-positive Breast Cancer
14%
Tumor Stage
14%
Drug Resistance
14%
Microenvironment
14%
Repurposing
14%
Miller
14%
Pathway Activation
14%
Enhanced Sensitivity
14%
Screening Data
14%
Cancer Resistance
14%
Type I Receptor
14%
Aromatase Inhibitors
14%
Fulvestrant
14%
Palbociclib
14%
Cyclin-dependent Kinase 4 (CDK4)
14%
ALK1
14%
P21Cip1
14%
Cip1
14%
Drug Sensitivity
14%
Mediated Growth
14%
Resistant Cells
14%
Secreted Factors
14%
Bone Morphogenetic Protein Receptor
14%
Breast Cancer Drugs
14%
Mothers against Decapentaplegic Homolog
14%
Shee
14%
Medicine and Dentistry
Cytokine
100%
Signal Transduction
100%
Estrogen Receptor
100%
Breast Cancer
100%
Bone Morphogenetic Protein 4
100%
Antiestrogen
50%
Upregulation
25%
Drug Resistance
25%
Bone Morphogenetic Protein
25%
Transcriptomics
25%
Cyclin-Dependent Kinase 4
25%
Neoplasm
12%
RNA Sequence
12%
Cell Growth
12%
Growth Inhibition
12%
Receptor
12%
Disease
12%
Primary Tumor
12%
Estrogen Therapy
12%
Immunoblotting
12%
Cell Cycle Arrest
12%
Breast Tumor
12%
Systemic Therapy
12%
Adjuvant Therapy
12%
Cancer Staging
12%
P21
12%
Tumor Microenvironment
12%
Cell Fate
12%
Breast Cancer Cell Line
12%
Mammalian Target of Rapamycin Complex 1
12%
Estrogen Receptor Positive Breast Cancer
12%
Receptor Protein
12%
Aromatase Inhibitor
12%
Cell Cycle Checkpoint
12%
Palbociclib
12%
Drug Sensitivity
12%
Estrogen Receptor Beta
12%
Fulvestrant
12%
Bone Morphogenetic Protein Receptor 1A
12%
RNAI
12%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Signal Transduction
100%
Estrogen Receptor
100%
Bone Morphogenetic Protein 4
100%
Upregulation
25%
Drug Resistance
25%
Bone Morphogenetic Protein
25%
SMAD
25%
Transcriptomics
25%
Cyclin-Dependent Kinase 4
25%
RNA Sequence
12%
Cancer Cell
12%
Cell Growth
12%
Cell Cycle Arrest
12%
Kinase
12%
Phosphotransferase
12%
Mammalian Target of Rapamycin Complex 1
12%
Cell Fate
12%
Cancer Staging
12%
P21
12%
Growth Inhibition
12%
Cell Cycle Checkpoint
12%
Aromatase Inhibitor
12%
Drug Sensitivity
12%
Activin Receptor
12%
Mothers against Decapentaplegic
12%
Estrogen Receptor Beta
12%
RNAI
12%
Immunoblotting
12%
Fulvestrant
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Breast Cancer
100%
Estrogen Receptor
100%
Bone Morphogenetic Protein 4
100%
Antiestrogen
50%
Receptor
25%
Bone Morphogenetic Protein
25%
Drug Resistance
25%
Cyclin Dependent Kinase 4
25%
Disease
12%
Neoplasm
12%
Primary Tumor
12%
Drug Development
12%
Mammalian Target of Rapamycin Complex 1
12%
Western Blot
12%
Breast Tumor
12%
Estrogen Receptor Positive Breast Cancer
12%
Tumor Microenvironment
12%
Cancer Staging
12%
RNA-Sequencing
12%
Palbociclib
12%
Fulvestrant
12%
Aromatase Inhibitor
12%
Estrogen Receptor Beta
12%
Bone Morphogenetic Protein Receptor 1A
12%